In this application for a Scientist Development Award for Clinicians (K- 20), we propose to study the effects of cocaine on the progression of HIV dementia (HIV associated cognitive / motor complex, or HIV-CMC) using modern neuroimaging techniques. A cross-sectional and longitudinal study in cocaine users and non-cocaine users with HIV-CMC will be performed. Cocaine is used illicitly by a large number of people, and has been shown to be immunotoxic in animals and possibly in man. Cocaine use is also a risk factor for HIV infection. Because HIV-CMC is caused by direct infection of the brain with HIV, we hypothesize that cocaine use leads to a more rapid progression of HIV-CMC in cocaine users compared to non cocaine users. Magnetic resonance imaging (MRI) will be performed to quantify changes in brain morphometry. As a quantitative measure of brain function, regional cerebral perfusion will be measured using single photon emission computed tomography (SPECT) and by a novel method, perfusion MRI. Finally, localized proton magnetic resonance spectroscopy (1H MRS) will be performed to assess cerebral biochemistry and neuronal viability. As a neurologist with some training in neuroimaging, the candidate (Linda Chang) is involved in a study on ethnic differences in the effects of cocaine use and in another study on the neurotoxicity of MDMA (""""""""Ecstasy""""""""). In order to conduct clinical research in drug abuse, the proposed study will allow her to combine her previous clinical and research experience, including dementia and AIDS, with the proposed supervised training in drug abuse and neuroimaging. The choice of preceptors reflects the interdisciplinary nature of the project; there is one preceptor for each area: drug neurotoxicity, neurochemistry, neurobehavior, and neuroimaging. This career and research plan will enable the applicant to develop as an independent investigator in the field of drug abuse research, with a focus on the application of state- of-the-art neuroimaging techniques to the study of drug-induced neurotoxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Unknown (K20)
Project #
1K20DA000280-01
Application #
2116348
Study Section
Special Emphasis Panel (SRCD (03))
Project Start
1995-09-30
Project End
2000-08-31
Budget Start
1995-09-30
Budget End
1996-08-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
City
Torrance
State
CA
Country
United States
Zip Code
90502
Ernst, Thomas; Chang, Linda (2008) Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol 3:165-72
Chang, Linda; Ernst, Thomas; Speck, Oliver et al. (2005) Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Am J Psychiatry 162:361-9
Chang, Linda; Ernst, Thomas; St Hillaire, Coryse et al. (2004) Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients. Antivir Ther 9:431-40
Ernst, Thomas; Chang, Linda (2004) Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS 18 Suppl 1:S61-7
Ernst, T; Chang, L; Arnold, S (2003) Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 19:1686-93
Ernst, T; Chang, L; Jovicich, J et al. (2002) Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 59:1343-9
Chang, Linda; Ernst, Thomas; Speck, Oliver et al. (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114:65-79
Goldstein, Rita Z; Volkow, Nora D; Chang, Linda et al. (2002) The orbitofrontal cortex in methamphetamine addiction: involvement in fear. Neuroreport 13:2253-7
Chang, Linda; Ernst, Thomas; Witt, Mallory D et al. (2002) Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage 17:1638-48
Chang, L; Speck, O; Miller, E N et al. (2001) Neural correlates of attention and working memory deficits in HIV patients. Neurology 57:1001-7

Showing the most recent 10 out of 13 publications